These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21282390)

  • 21. [Case report; a case of biliary pseudolithiasis associated with ceftriaxone].
    Hanata N; Imamura T; Koyama R; Koizumi Y; Tamura T; Ito J; Takeuch K
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2955-7. PubMed ID: 23214106
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ceftriaxone-associated biliary pseudolithiasis in a child with nephrotic syndrome].
    Zheng FY; Xing Y; Lu S; Liu DM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):696-7. PubMed ID: 23965889
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H
    Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis.
    Kim S; Gura KM; Puder M
    Pediatr Surg Int; 2006 Jun; 22(6):562-4. PubMed ID: 16485100
    [No Abstract]   [Full Text] [Related]  

  • 25. Ceftriaxone and pseudolithiasis in older people.
    Miyamoto T; Ebihara T; Kozaki K
    Geriatr Gerontol Int; 2018 Mar; 18(3):507-509. PubMed ID: 29542293
    [No Abstract]   [Full Text] [Related]  

  • 26. Ceftriaxone-induced pseudolithiasis: not just a theoretical risk.
    Fan L; Lau P; Kapur J; Karthik SV
    Singapore Med J; 2017 Nov; 58(11):676-677. PubMed ID: 29167906
    [No Abstract]   [Full Text] [Related]  

  • 27. Ceftriaxone-induced biliary pseudolithiasis and urinary bladder sludge.
    Acun C; Erdem LO; Sogut A; Erdem CZ; Tomac N; Gundogdu S
    Pediatr Int; 2004 Jun; 46(3):368-70. PubMed ID: 15151561
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gallstones in association with the use of ceftriaxone in children].
    Rodríguez Rangel DA; Pinilla Orejarena AP; Bustacara Diaz M; Henao García L; López Cadena A; Montoya Camargo R; Moreno LA
    An Pediatr (Barc); 2014 Feb; 80(2):77-80. PubMed ID: 23759541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrolithiasis in a child with acute pyelonephritis. Ceftriaxone-induced nephrolithiasis and biliary pseudolithiasis.
    Tasic V; Sofijanova A; Avramoski V
    Pediatr Nephrol; 2005 Oct; 20(10):1510-1, 1512-3. PubMed ID: 16082553
    [No Abstract]   [Full Text] [Related]  

  • 30. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?
    Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R
    Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftriaxone-associated Pseudolithiasis in Elderly People: Frequency and Risk Factors.
    Hotta K; Hashimura N; Takatsuka M; Matsuyama T; Nakagawa K; Yabusako T; Hosomi S; Fujiwara Y
    Intern Med; 2021; 60(24):3857-3864. PubMed ID: 34911872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pseudolithiasis caused by ceftriaxone in children: a case report].
    Benedetti M; Zanchetta S; Bagnani A; Praderio R; Perbellini S; Melo C
    Pediatr Med Chir; 1995; 17(4):369-71. PubMed ID: 7491336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftriaxone-associated biliary pseudolithiasis in paediatric surgical patients.
    Ceran C; Oztoprak I; Cankorkmaz L; Gumuş C; Yildiz T; Koyluoglu G
    Int J Antimicrob Agents; 2005 Mar; 25(3):256-9. PubMed ID: 15737522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children.
    Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M
    Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute urine retention induced by ceftriaxone.
    Akl KF; Masri AT; Hjazeen MM
    Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1226-8. PubMed ID: 22089789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of ceftriaxone-associated gallbladder pseudolithiasis.
    Papadopoulou F; Efremidis S; Karyda S; Badouraki M; Karatza E; Panteliadis C; Malaka K
    Acta Paediatr; 1999 Dec; 88(12):1352-5. PubMed ID: 10626521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults.
    Li ZL; Li HL; Chen HW; Li HC; Zhang P; Wang ZM; Chong T
    Int Urol Nephrol; 2013 Feb; 45(1):73-6. PubMed ID: 23180444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction.
    Imafuku A; Sawa N; Sekine A; Kawada M; Hiramatsu R; Yamanouchi M; Hasegawa E; Hayami N; Hoshino J; Ubara Y; Takaichi K
    Clin Exp Nephrol; 2018 Jun; 22(3):613-619. PubMed ID: 29027036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftriaxone-related hemolysis and acute renal failure.
    Demirkaya E; Atay AA; Musabak U; Sengul A; Gok F
    Pediatr Nephrol; 2006 May; 21(5):733-6. PubMed ID: 16491410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature.
    Bickford CL; Spencer AP
    Pharmacotherapy; 2005 Oct; 25(10):1389-95. PubMed ID: 16185184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.